Thomas Gad
CIK 1753224 · CHIEF BUSINESS OFFICER · last filed 2025-09-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
103
Lifetime Open-Market Net
-$47.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | CHIEF BUSINESS OFFICER | 365,721 | $8.61 | $3.15M | -$47.45M | 102 | 2025-06-05 |
Recent Filings · Page 5 of 11
103 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-20 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Sell (S) | −4,000 | -$136.3K | EDGAR |
| 2021-04-28 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Mixed | — | -$181.7K | EDGAR |
| 2021-04-14 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Mixed | −4,000 | -$278.6K | EDGAR |
| 2021-04-05 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Mixed | −6,000 | -$435.9K | EDGAR |
| 2021-03-17 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Mixed | −4,000 | -$390.7K | EDGAR |
| 2021-03-12 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Other (J) | +1,029,927 | $0 | EDGAR |
| 2021-03-03 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Mixed | −6,000 | -$514.6K | EDGAR |
| 2021-02-18 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Mixed | −4,000 | -$503.9K | EDGAR |
| 2021-02-03 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Mixed | −4,000 | -$447.8K | EDGAR |
| 2021-01-21 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Mixed | −4,000 | -$497.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.